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ABSTRACT OF THESIS

DISSECTING THE ROLE OF ACTIN-MYOSIN MOTOR AND CALCIUM – BASED
ORGANELLE SECRETION IN MOTILITY OF SARCOCYSTIS NEURONA
Sarcocystis neurona is a protozoan parasite that causes a rare neurological disorder
in horses called Equine Protozoal Myeloencephalitis (EPM). Apicomplexa use actinmyosin based motor and organelle secretion to interact with the host cell and invade it.
Despite the importance of motility and invasion-needed factors, the mechanisms by which
S. neurona employs host cell association strategies to interact remains largely undefined.
To address this knowledge gap, we hypothesize that just like other Apicomplexa, S.
neurona utilizes actin polymerization for substrate-dependent gliding. Moreover, we also
hypothesize that micronemes of S. neurona secrete proteins that are calcium-dependent.
Based on previous studies in T. gondii, freshly harvested S. neurona merozoites are treated
with actin-polymerization inhibitor (Cytochalasin-D) or intracellular-calcium inducers
(Ethanol, ionophore A23187) or intracellular-calcium chelator (BAPTA-AM) or bumpedkinase inhibitor (BKI-1553). Data obtained from each experiment is analyzed to assess
whether there is any variation in motility/secretion upon treatment with previously
mentioned drugs. Results suggest that S. neurona employs actin-myosin motor and likely
calcium-based microneme secretion for motility; implicating the role of host-parasite
interactions in EPM since motility/secretion is required for causing infection.

KEYWORDS: Sarcocystis neurona, Host-Pathogen Interactions, Motility, Gliding,
Microneme Secretion, Calcium Signaling
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CHAPTER 1. PARASITES
Parasitism is a type of relationship between organisms where sometimes one feeds on
another for resources. Some parasites are considered good for host health, but some
endanger health of people that are mostly living in underprivileged conditions [1]. One
such example where parasites are good for health is when parasites provide useful
micronutrients to the infected host, as observed in trypanosomes [1]. Parasites can be
ectoparasites, which live outside the host’s body (like Pediculus humanus humanus) or
endoparasites which live inside the host’s body (like Schistosoma mansoni) [1]. A
parasite’s survival in the host is dependent on various factors. First, identification of an
appropriate host is crucial. An example of high specificity of host interaction would be
malaria infecting humans, but not infecting monkeys. Another factor can be the
establishment of a productive infection that leads to generation of progeny. A mechanism
to establish an appropriate niche within the host by targeting the appropriate tissue for
growth and transmission can also affect the parasitic lifestyle. Parasites may have an
environmental form where they are usually not replicating but staying dormant inside the
host until they become active. The major point to consider is the mechanism by which a
parasite minimizes both innate and acquired immune responses of the host as a
developmental signal for a parasite like Toxoplasma gondii [1]. Establishing a balance
between reproduction rate (to maintain host viability) and potential to spread to a new host
is also important for a parasite’s survival. Some parasites, like arthropods and molluscs, do
not directly cause a disease and thus act as vectors, or reservoirs, for other infections
transmitted by bacteria and viruses.

1.1

Protozoa

A parasite can be a single celled eukaryote (protozoa) or a multicellular eukaryote
(metazoan) which includes helminths and arthropods. Protozoa are traditionally classified
on their characteristics of motility. Amoebae uses ameboid-crawling motion on a substrate.
Flagellates like Giardia lamblia or Trichomonas vaginalis can use one or more whip like
flagella, while sporozoa use gliding motility on substrates as in Plasmodium spp. Some
parasites are ciliates like Balantidium coli which use cilia for movement. Given the
1

complex life cycle of parasites, a host may be classified as definitive, intermediate. A
parasite passes its adult phase (in metazoa) or the sexual reproductive phase (in protozoa)
through a definitive host, whereas it passes through its larval (in metazoa) or asexual (in
protozoa) stage through an intermediate host. Highly specific parasites may undergo both
phases of development within a single host as in Cryptosporidium. The protozoan phylum
Apicomplexa includes more than 5,000 species that depict multiple cell types and host
species that can cause mortality to humans and agricultural animals (Fig. 1.1-1) [2]. The
word “Apicomplexa” refers to the characteristic apical end of these parasites. The
Apicomplexa discussed in this work are selected on the basis of their medical and
agricultural importance. Most of the research has been conducted on only important human
pathogens like Plasmodium spp. (Malaria, potentially deadly disease [3]), Toxoplasma
gondii (Toxoplasmosis, chronically affected one-third of the human population [3]),
Cryptosporidium spp. (Cryptosporidiosis, infects 8–10 million people per year [3]),
Babesia spp. (Babesiosis) and important veterinary pathogens like Eimeria tenalla
(Coccidiosis), Sarcocystis spp. (Sarcosporidiosis), Babesia spp. (Babesiosis), Theileria
(Theileriosis, cattle pathogen). All Apicomplexa are obligate intracellular pathogens and
use diverse replication strategies [4].
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Toxoplasma
Plasmodium
Cryptosporidium

Figure 1.1-1 Diagram of eukaryotes depicting diversity among protozoan parasites.
Illustration is adapted from [80]. Note: Image represents only diversity and not
relationships.

Toxoplasma gondii, another Apicomplexa parasite, causes toxoplasmosis. Toxoplasmosis
can be acquired from the droppings of infected cats (definitive host) as well as the
consumption of meat contaminated with tissue cysts which affect intermediate host [6] T.
gondii is an opportunistic pathogen which can infect all warm blooded animals. In humans,
it can cause toxoplasmosis in the immunocompromised or congenitally infected children
where severe form of the disease is observed. T. gondii infection is inherited only during
the earlier stages of infection in the mother. T. gondii infestation does not show any clinical
signs in both definitive and intermediate hosts. Toxoplasmosis can show various
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manifestations in humans such as lymphadenitis (most common) and encephalitis (severe
form). T. gondii affects the brain and retina of infected individual. Milder forms of
toxoplasmosis may involve somewhat reduced vision. Instead, it shows classic quadruple
signs in children with severe form; such as retinochoroiditis, hydrocephalus, convulsions,
and intracerebral calcifications. Animals other than humans can also be severely affected
by T. gondii. The parasite is capable of causing abortion in goats and sheep in many
countries. Toxoplasmosis can lead to pneumonia, hepatitis, and encephalitis in cats, dogs
and other pets which can be fatal [7, 8]. Humans getting infected by T. gondii is widespread
throughout the world since it is an extremely prevalent parasite. However, people who
acquire the infection congenitally is less than 0.1 percent of the total population [8].
The definitive hosts for toxoplasmosis include members of the family Felidae, whereas
warm-blooded animals serve as the intermediate hosts. Infection begins when the definitive
host ingests any of the three stages of T. gondii such as rapidly multiplying form called
tachyzoites, dormant form called bradyzoites that inhabit tissue cysts, and oocysts that are
shed in the feces. These oocysts are not susceptible to the majority of environmental
conditions and thus can survive in infected tissue for longer time periods. Bradyzoites from
the tissue cysts or sporozoites released from oocysts invade the intestinal epithelial cells
and simultaneously multiply in the intestine [7].
Various ways to diagnose toxoplasmosis in humans include serological, histological or
molecular-based examination. Differential diagnosis is required since clinical signs may
imitate other infectious diseases. Serological assays involve detection of antibodies against
T. gondii in Sabin–Feldman dye test, the indirect hemagglutination test, the indirect
fluorescent antibody test (IFA), the direct agglutination test, the latex agglutination test
(LAT), the enzyme-linked immunosorbent assay (ELISA) and the immunosorbent
agglutination assay test (IAAT) [7]. Drugs such as sulphadiazine and pyrimethamine are
used for traditional treatment of toxoplasmosis [7].
T. gondii acts as a perfect model system for studying some similar Apicomplexa.
Advantages of using T. gondii as a paradigm include well established molecular genetic
tools (mutagenesis, high frequency transformation, CRISPR-Cas9 system, conditional
knockout system); proteomics tools (RNA-seq, SAGE); in vivo model and biochemistry.
4

T. gondii, which can infect any nucleated cell without using an insect vector, undergoes
endodyogeny. In contrast to T. gondii, the Plasmodium spp. life cycle undergoes three
phases—schizogony,

gamogony,

and

sporogony—including

various

stages

of

development in the Anopheles vector and the mammalian host. Sporozoites get transmitted
by the saliva of the vector followed by transport via blood to hepatocytes, where they
mature into schizonts. These schizonts then multiply and mature into merozoites that
degrade host cell membrane to infect other hepatocytes or erythrocytes (schizogony). Some
of these parasites differentiate into gametocytes (sexual stage) within erythrocytes
followed by ingestion by the Anopheles mosquito during a blood meal [9].
Theileria spp. secrete infective sporozoites onto the site where tick feeds and infect
leukocytes. It is the only eukaryotic pathogen known to transform lymphocytes [10].
Sporozoites then replicate into merozoites that enter the erythrocytes and establish the
characteristic piroplasm stage. These piroplasms are ingested by a vector (such as a tick)
during the next blood meal. The released parasites undergo syngamy in the tick’s gut
followed by motile kinetes traveling to salivary glands. They then undergo sporogony to
form sporozoites in the salivary gland before injection by the vector tick [11].
Sarcocystis spp., on the other hand, has an obligatory two-host life cycle. The asexual
stages such as schizonts and sarcocysts as tissue stages, grow only in the intermediate host
(Fig. 1.1-2). The sexual stages develop only in the definitive host. Intermediate and
definitive hosts vary for each species of Sarcocystis [12-14]. Opossum (Didelphis
virginiana in North and D. albiventris in South) serves as the definitive host in both North
and South America for S. neurona. Sporozoite-containing sporocysts of the parasite are
produced due to sexual reproduction in the intestinal epithelium of the infected opossum
and are passed in the feces. The sporozoites infect the intermediate hosts such as skunks
[15], raccoons [16], armadillos [17], and cats [18] for S. neurona. S. neurona forms
dormant sarcocysts in the muscle tissue of the intermediate host and act as a source of
infection for opossum. Horses are considered to be accidental/aberrant host upon ingestion
of food and water contaminated with feces from S. neurona infected opossum [19]. Horses
cannot pass S. neurona between themselves, nor can horses pass it on to non-equine as
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intermediate hosts. It is not known how S. neurona enters the central nervous system, but
it is thought that either endothelial cells or leukocytes are afflicted [20-23].

Figure 1.1-2 Life cycle of S. neurona depicting sexual replication in definitive host and
asexual propagation in intermediate host.
Horse acts as an aberrant host. Illustration is adapted from [30].
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1.2

Equine Protozoal Myeloencephalitis

Sarcocystis neurona is the main etiological agent of a neurological disorder called Equine
Protozoal Myeloencephalitis (EPM). It has been reported to be prevalent in countries such
as the United States [24, 25] , Mexico [26], and Brazil [27], among others. Horses have a
variable seroprevalence of antibodies against S. neurona (10% in Utah [24], 22% in Oregon
[25]), but clinical disease incidence is generally low (around 1%) [28]. Clinical signs
associated with EPM include progressive ataxia, focal muscle atrophy, gait asymmetry,
and cranial nerve deficits [29]. Sites of infection involve brain, brain stem or spinal cord.
Necropsy examination of EPM cases have revealed manifestation of lesions on cut surfaces
of the CNS, ranging from clearly demarcated discoloration (usually of gray matter) to
massive lesions that destroy whole segments of the brain or spinal cord. Less than half of
reported cases show parasites histologically. Standard staining procedures (such as
hematoxylin

and

eosin)

can

make

parasite

detection

difficult,

but

after

immunohistochemical staining the parasites may be clearer (Fig. 1.2-1). Extensive analysis
of EPM clinical cases show cuffing of blood vessels by mononuclear cells, necrosis of
parenchyma with phagocytosis and astrocyte proliferation. Presence of eosinophils and
multinucleated cells (increased in size) in such lesions is common [24].
To diagnose EPM definitely, postmortem confirmation of S. neurona infection of the CNS
is required. In order to confirm intrathecal antibody production against S. neurona, a
complete neurological examination is carried out as well as immunodiagnostic testing of
serum and CSF [12]. This is indicative of active parasite infection. Differential diagnosis
should be performed in order to rule out other diseases that show similar clinical signs.
Traditional treatment of EPM has included frequent use of combination of anti-folate drugs
such as pyrimethamine and sulfonamide for some decades [12]. Side effects of such drugs
are usually not serious and involve bone marrow suppression, anorexia, diarrhea, mild
anemia, neutropenia. Also, pyrimethamine is prohibited from being used to treat pregnant
mares [12]. However, the alternatives to these drugs, diclazuril and ponazuril are approved
for EPM treatment. Diclazuril and ponazuril are benzeneacetonitrile anticoccidials that
have a broad-spectrum associated impact on various animal species [12]. In addition to the
treatment being expensive, the equine industry is heavily impacted because of the
7

incapacity of the horses to recover to their previous performance level. The success rate
after 28 days of treatment with these drugs is around 60%, with success being defined as
improvement of clinical signs by at least one neurologic grade. Due to the lack of a highly
effective treatment option in the horses, probable molecular targets specific for this parasite
can be found for future therapeutic interventions using a combination of metabolomics,
genomics, and transcriptomics [12].

8

Figure 1.2-1 S. neurona in histological sections of spinal cord of a horse infected with
EPM.
(A) Areas of spinal cord depicting heavy parasitization (merozoites and schizonts in red).
(B) A heavily parasitized axon with merozoites (arrowheads) showing myelin degeneration
(arrows) using haematoxylin and eosin stain. (C) Numerous schizonts in infected neuron.
(D) Intraneuronal merozoites (notched arrows) and schizont (arrow) in an intact neuron.
Images are obtained from [30] and used with author’s permission.
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Proliferation of these coccidian parasites begins with invasion of a host cell, followed by
parasite replication and cell division until the host cell is lysed by the replicated parasites
[4]. Such parasites do not grow or undergo cell division extracellularly and thus require
invasion of other host cells to survive [4]. Multiple cycles of invasion and egress by the
tachyzoite stage of a parasite into host cells is responsible for causing tissue damage and
inflammation, representative of the disease symptoms [31]. Many Apicomplexa parasites
are known for their ability to grow and replicate within the parasitophorous vacuole (PV),
which is a non phagosomal, membrane bound compartment [4].
S. neurona merozoites that infect the aberrant host (horse), invade a host cell and initiate
intracellular development by transforming into schizonts. Sarcocystis schizonts multiply
in host cytoplasm and give rise to 64 merozoite daughters after going through multiple
stages of schizogonic development for 3 days (Fig. 1.2-2) [29, 32]. During these
schizogonic stages, schizonts and merozoites are located in the host cell cytoplasm without
a PV [29]. After the completion of intracellular development, merozoites formed disperse
and leave the host cell. The schizogonic cycle can be asynchronous; having schizonts of
different maturity in a single host cell.
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Figure 1.2-2 Immunofluorescence images showing different stages of S. neurona SN3
strain life cycle.
Blue – host cell nuclei, green – yellow fluorescent protein tagged S. neurona. A. Early
schizont stage of parasites at 8 hpi B. Mid schizont stage of parasites at 24hpi C. Mature
schizont stage of parasites at 48hpi D. Dispersing merozoites at 72hpi. Hpi = hours postinfection. Images are obtained from the lab of Dr. Daniel Howe.

T. gondii shares some similarities as well as differences with S. neurona. T. gondii has a
complex life cycle that consists of different stages in the intermediate host, tachyzoites and
bradyzoites. Tachyzoites divide rapidly, disseminate throughout the body and differentiate
into bradyzoites. Bradyzoites develop in muscle and neuronal cells of the infected host
[33]. The different stages of this parasite; tachyzoites, bradyzoites and sporozoites; are
similar in general morphology. However, tachyzoites reside within a PV and bradyzoites
reside within a tissue cyst that is also a membrane-bound intracellular compartment.
A typical Apicomplexa cell contains various specialized structures and virulence factors
which are important for invasion and replication of the parasite inside the host cell (Fig.
1.2-3). Structural studies with T. gondii, Eimeria and Plasmodium have revealed that the
anterior pole of the infective forms (trophozoites, merozoites, sporozoites) of crescent
shaped Apicomplexa cell, termed a zoite, is a distinct collection of specialized structures
called the apical complex [34]. The apical complex typically comprises several cytoskeletal
features, such as a polar ring and a conoid, and secretory organelles called micronemes and
rhoptries [35, 36]. Other sets of secretory organelles such as dense granules have been
11

reported to be present in some species of Apicomplexa. The secretory organelles of the
apical complex have been proposed to pay a role in the organisms’ ability to invade host
cells and establish an intracellular environment that facilitates survival and proliferation
[37].

Figure 1.2-3 An Apicomplexa zoite showing specialized structures and secretory
organelles important for parasite survival. Illustration is adapted from expert reviews in
molecular medicine, 2001.
1.3

Micronemes

Micronemes are small, cigar-shaped organelles present at the apical end of the protozoan
body. Species and the stages of development determine the number of micronemes in a
parasite. This organelle is rarely seen in some species whereas is the most abundant in
others. The electron dense matrix is made up of a large amount of proteins and is
surrounded by a typical membrane unit. It has been reported that all microneme proteins
12

contain an N-terminal signal sequence that facilitates translocation across the endoplasmic
reticulum membrane to reach the secretory pathway [38]. As well, Apicomplexa parasites
have been shown to trigger Ca2+ release and microneme discharges at the interface between
the parasite and the host when their infective forms reach the host cell surface [39-41]
which then mediates parasite attachment [39, 42, 43]. A few seconds later, the microneme
proteins (MICs) released from the protozoan’s posterior end are not incorporated with the
parasites but instead are capped and released into the host cell [39]. According to studies
conducted on parasites, transmembrane MICs communicate with external receptors via the
sub-membranous acto-myosin motor during redistribution on the parasite’s surface. This
facilitates parasite movement [38]. A number of microneme proteins have been found to
work together in T. gondii to achieve attachment and invasion [44].
A burst of microneme release is triggered in response to host cell contact, which appears
to be highly regulated [45]. Intracellular calcium is mainly stored in the acidocalcisomes,
mitochondria, and endoplasmic reticulum in Apicomplexa (Fig. 1.3-1). Microneme
secretion during host cell invasion may involve some or all of these stores. According to
previous binding studies, microneme proteins might attach to host cell surfaces during
invasion, and the transmembrane form of the adhesin MIC2 may act as a molecular link
between host cell and parasite during invasion. Additionally, these studies show that
microneme secretion in T. gondii is mediated by increase in intracellular calcium.
Researchers have observed that microneme secretion and invasion are blocked by chelating
T. gondii calcium [39]. T. gondii calcium levels are known to be enhanced by agents such
as calcium ionophore A23187, ionomycin, ethanol and thapsigargin, an ATPase inhibitor
of sarco-endoplasmic reticulum. There is evidence that these molecules can stimulate
microneme discharge even in the absence of host cells [42, 43]. An intracellular calcium
release channel with inositol 1,4,5-triphosphate/ryanodine receptor superfamily-like
characteristics has been described previously. Nevertheless, much remains unknown about
the mechanism that triggers the calcium-mediated release of micronemes in both
artificially-triggered and naturally-triggered invasion [5].
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Figure 1.3-1 Schematic showing microneme secretion and calcium-mediated signaling
pathways in T. gondii.
Chemical inducers or inhibitors (┬) are also shown. MIC, micronemal proteins; CDPK1,
calcium-dependent protein-kinase 1; PIP2, Phosphatidylinositol 4,5bisphosphate; PLC,
Phospholipase C; DAG, Diacylglycerol. Illustration is adapted from [5].

A recently identified microneme protein in S. neurona is SnMIC10 which is similar to
TgMIC10 of Toxoplasma gondii and NcMIC10 of Neospora caninum [46]. Just like other
Apicomplexa [45, 47-49], secretion of SnMIC10 displays temperature and time sensitivity
with increased release of protein at 370C and no/minimum release at 00C when incubated
for 30 minutes (Fig. 1.3-2) [37].

14

Figure 1.3-2 Western blot results from previous study on SnMIC10 using extracellular S.
neurona merozoites depicting
(A) SnMIC10 is obtained in secretory fraction and is time-dependent. Secretory samples
were incubated for 0 or 30 min at 370C and subsequently supernatant was probed for rabbit
anti-SnSAG4, rabbit anti-SnMIC10 antibodies. (B) SnMIC10 secretion is temperaturedependent. Secretory samples were incubated for 30 min at 0, 25 and 370C and supernatant
was probed for rabbit anti-SnSAG4, rabbit anti-SnMIC10 antibodies. Images are obtained
from [37].
1.4

Host Cell Invasion

The non-Apicomplexa protozoan parasites invade the host cell by phagocytosis or
receptor-mediated endocytosis, whereas in Apicomplexa, parasites use a process of gliding
motility—a substrate-dependent locomotion—for invasion [46]. Cryptosporidium parvum
reorganizes the gut endothelial cell cytoskeleton of its host, which leads to actin
polymerization while interacting with its plasma membrane. After pulling the host
membrane around itself, the process forms a feeder organelle in the host for parasite-host
15

interaction, instead of invading deep into the host cell. In contrast, Toxoplasma gondii
tachyzoite glides into the host cell by forming a vacuole around itself from the host’s cell
membrane. In Plasmodium falciparum, the sporozoite stage that survives in mosquitoes,
acts similarly to T. gondii. Invasion of red blood cells occurs by P. falciparum merozoites
in combination with motility and zippering. Non-motile sporozoites or merozoites of
Theileria enter the host cell by the process of zippering. Zippering is a type of invasion
where the parasite makes its way into the host cell in any orientation and seals the host
membrane behind it, thereby lyses the cell and survives as free living [46].

Active invasion of host cell in Apicomplexa comprises some sequential steps:
The motile extracellular stage of any Apicomplexa parasite, referred to as a zoite, is an
elongated and polarized cell. The micronemes contain molecular adhesins in soluble and
transmembrane forms that aid in attachment of the parasite to the host cell [44, 45, 47].
Following the attachment of parasite, host cell invasion includes filtration of
transmembrane proteins from the nascent vacuole. It migrates inwards into an invagination
of the host-cell surface that becomes the nascent parasitophorous vacuole (PV) after
pinching off from the host cell plasma membrane [48], followed by rhoptry secreting
proteins (termed as Rhoptry Neck Proteins). Dense granules are secreted by the parasite
after it has entered the host-cell during remodeling of the vacuole. Such secreted effectors
have been shown to play a critical role during T. gondii pathogenesis by creating a safe
environment in PV and modulating host response against infection.

SnSPR1, a surface antigen unique to Sarcocystis genus, is distinctive to the biology of
Apicomplexa. S. neurona merozoites express a family of such four surface antigens.
Western blot analysis of S. neurona fractions demonstrate SnSPR1 to be likely associated
with parasite’s surface membranes. Additionally, indirect immunofluorescence
microscopy images have revealed that SnSPR1 is expressed in each merozoite and
throughout all stages of schizont development. However, SnMIC10 is expressed only in
mature schizonts (Fig. 1.4-1) [53].
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Figure 1.4-1 Immunofluorescence assay to observe localization of SnSPR1 and SnMIC10
during different stages of S. neurona development
(A) Late stage schizonts (B) Intermediate stage schizonts. Each merozoite was labeled with
either SnSPR1 (arrow, green) or SnMIC10 (arrow, red). SnSPR1 is present throughout
intracellular development of S. neurona whereas SnMIC10 was absent/very dim during the
intermediate stage. SnSPR1 labeled the whole schizont circumference but SnMIC10 was
present only at the apical end of the parasite. Labeled in blue was host cell nuclei using
4,6-diamidino-2-phenylindole. Images are obtained from [53].
1.5

Parasite Motility

Many unicellular eukaryotic cells move by crawling, a process called amoeboid motion.
A controlled assembly and disassembly of the actin cytoskeleton is required for this type
of motion [54]. Migration modes can be used by migrating cells in response to their
microenvironment, which enables them to move even without adhesive coupling. An
Apicomplexa parasite study recently revealed that actin is crucial to defining and releasing
attachment sites, which suggests that Apicomplexa motility may resemble amoeboid-like
crawling [54]. Gliding motility is a defining feature for the phylum Apicomplexa. In T.
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gondii, however, the actomyosin system seems to show functional redundancy of
actomyosin components [54]. Instead of using cilia or flagella for its motion, T. gondii uses
its own substrate-dependent motility system for active penetration of the host cell.
Among the most abundant proteins in eukaryotic cells is actin. The actin-based gliding
locomotion is controlled by a multiprotein complex called “glideosome” that is located
between the parasite’s plasma membrane (PM) and two membranes known as the inner
membrane complex (IMC) [55]. Positioning of apical pole of the parasite towards the host
cell plasma membrane acts as a precursor to the invasion process. Attachment to the host
cell is followed by host cell invasion driven by an actomyosin motor in the inner membrane
complex of the parasite. This leads to formation of “moving junction” (MJ) which is a ringlike structure that connects parasite’s apical tip with the host cell membrane [56]. MJ
connects the cortical cytoskeletons in the two (host-parasite) cells [57] and filters
transmembrane proteins from the nascent vacuole. This is followed by rhoptry secreting
RON proteins into the MJ. Some Apicomplexa like Babesia bovis [58] and Theileria spp
[59], however, do not always have this specialized vacuole throughout the intracellular
parasite stage. Infection of the host-cell allows these parasites to escape the PV [59].
Glideosome is functional due to interaction of the Myosin A (MyoA) motor complex,
parasite actin and micronemal transmembrane proteins of the TRAP family that interact
with actin via the glycolytic enzyme aldolase (Fig. 1.5-1). This has been termed as the
linear motor model. Parasite and the host cell forms a tight junction when micronemes and
rhoptries secrete sequentially, and it has been postulated that the gliding machinery
provides the necessary force for the penetration process through the junction [60].

18

Figure 1.5-1 Schematic model of molecular mechanism that drives gliding motility in
Apicomplexa parasites.
Transmembrane adhesive proteins (TRAP, shown in gray) interact with the myosin
(brown) that are embedded into the parasite plasma membrane at various sites of interaction
between parasite and substrate. This complex interacts with the receptor (red) present on
the surface of the substrate. The translocation of adhesion-receptor complex occurs due to
motility of the parasite, which is powered by the myosin motor along actin filaments
(yellow). Illustration is adapted from [91].

Based on the ‘linear motor’ model, the parasite secretes MIC2 (micronemal transmembrane
protein) at its apical pole in T. gondii. By interacting with the substrate and the actomyosin
system, the host cell can glide forward on the substrate or enter the host cell [54]. As
depicted in figure 1.5.1, both actin-like filaments and myosin are situated under the parasite
plasma membrane in T. gondii. The motor used by T. gondii and P. falciparum have been
found to be kinetically and mechanically fast in motion. It has also been observed that
glideosome gets post-translationally modified before its operation in these two parasites
[61].
The host-parasite interaction complex is considered as receptor-ligand based. The
attachment of glideosome to the parasite cytoskeleton followed by its interaction with the
receptors on host cell surface, helps the parasite to propel forward. Cytoskeletal elements
and secretory organelles are the key players acting in a concerted manner for motility that
19

is modulated by regulation of molecules involved in signaling cascades. Pellicle of a typical
Apicomplexa zoite is comprised of three layers such as plasma membrane, underlying outer
and inner membrane (constitute the IMC) [61]. Translocation of microneme proteins (also
called as adhesins) on parasite plasma membrane has been historically linked with parasite
motility in P. berghei sporozoites [62]. These adhesins act as specific ligands for host cell
receptors. Like other Apicomplexa, S. neurona has been reported to glide on a substrate by
shedding its surface antigen which gets deposited in the form of trails as the parasite moves
along the substrate (Fig. 1.5-2) [63]. As observed in T. gondii, gliding is comprised of three
types of movements – circular motion, twirling and helical motion. Major difference
between helical gliding and twirling is that during helical motion, parasite lies horizontally
on the substrate and undergoes clockwise circulation along the long axis of its body while
keeping itself attached to the substrate [64].

Figure 1.5-2 S. neurona merozoite (shown in solid green) gliding is visualized by trails
(shown in dotted green) deposited on a glass slide under a fluorescence microscope.
Trails are stained using antibody against surface antigen SnSAG4. Image is obtained from
the lab of Dr. Daniel Howe.
Regulation of the activity of glideosome still remains unexplored in some Apicomplexa.
Calcium has long been recognized as a conserved second messenger and principal mediator
in plant immune and stress responses. It has been noted in both T. gondii and Plasmodium
spp. that intracellular calcium in parasites increase during alteration in integrity of infected
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host cell. This increase in calcium concentration leads to cell signaling through activation
of certain kinases followed by microneme secretion. This affects gliding motility, invasion
and egress. Calcium signaling apparatus in higher animals include calmodulin-dependent
kinases which are absent in Apicomplexa. However, this absence is replaced by various
calcium-dependent protein kinases (CDPKs) that are usually present in plants [61].
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CHAPTER 2. DISSECTING THE ROLE OF ACTIN-MYOSIN MOTOR AND
CALCIUM – BASED ORGANELLE SECRETION IN MOTILITY OF
SARCOCYSTIS NEURONA
2.1

Introduction

Even though Apicomplexa exhibit the complexity and diversity in their lifestyles, some of
them share a conserved mechanism for gliding and active invasion. Gliding is a substratedependent locomotion which requires synchronized activity of multiple proteins. Once the
extracellular parasite glides over the host cell surface, it reorients itself to interact with the
host cell in order to invade [80]. Apicomplexa possess secretory organelles such as
micronemes and dense granules. Expressed sequence tag (EST) project along with other
molecular studies has been used to predict the abundance of previously mentioned proteins
in S. neurona merozoites. One such protein is SnMIC10, a microneme-secreted protein.
Based on the observations in T. gondii and S. neurona, microneme secreted proteins are
transiently present at the parasite’s apical surface [44, 51]. Moreover, previous studies have
shown that mature SnMIC10 protein is 216 amino acid long and 24kDa in molecular
weight. Location of SnMIC10 at apical end of micronemes has been observed via
immunofluoresecent labeling studies in extracellular merozoites of S. neurona [37].
S. neurona surface proteins, known as SnSAGs, are relatively abundant and
immunodominant. These proteins belong to the family of glycosylphosphotidylinositol
(GPI) – anchored surface antigen and have been shown to be orthologues of the other
coccidians T. gondii [65, 66] and Neospora spp. [67-70]. SRS (SAG-related sequence)
proteins have been demonstrated to be involved in receptor-ligand interactions with the
host cell surface in T. gondii [71-74].
Calcium is a known second messenger that plays crucial role in invasion of mammalian
cells by various pathogens. Many obligate-intracellular parasites modify the calcium-based
host cell signaling during invasion.
Cytochalasin-D (CD) belongs to a class of cell-permeable fungal metabolites that affects
phagocytosis and movement in vertebrate cells. CD has been shown to inhibit actin
polymerization in vitro. It binds to the end of growing chain of actin filaments (F-actin)
22

and prohibits incorporation of globular G-actin monomers [75]. Previously, it has been
shown that CD blocks both gliding motility and invasion of phagocytic and non-phagocytic
cells. Both the parasite and host cell carry actin-based cytoskeleton in case of eukaryotic
parasites [76]. The findings from various previous studies have been based on the
Apicomplexa such as T. gondii, P. berghei [61]. It has been observed that the treatment
with CD can result in inhibition of parasite movement and disruption of host cell
microfilament. However, T. gondii has exhibited dependency on parasite’s cytoskeleton
instead of host cell microfilaments for motility [76]. It has also been reported previously
that CD is involved in alteration of ion flux related to calcium channels [83].
Calcium dependent protein kinases (CDPKs) belong to a class of calcium-binding proteins
involved in signal transduction that are highly abundant in green algae, higher plants and
Apicomplexa but are absent in animals. CDPKs are serine/threonine kinases that have been
shown to be validated targets in many Apicomplexa for anti-Apicomplexa drugs [77].
Apicomplexa CDPKs are involved in many cellular pathways including attachment,
invasion, and egress [77]. 8 CDPK-specific genes have been identified in S. neurona that
are orthologous to T. gondii CDPKs [84]. It has been observed that microneme secretion
and host cell invasion by T. gondii is dependent on intracellular calcium of the parasite [41,
43]. Moreover, T. gondii protein secretion is regulated by the CDPKs [77]. The inhibitors
that target Apicomplexa CDPKs are termed as bumped-kinase inhibitors (BKI). BKIs have
been shown to inhibit growth of various Apicomplexa parasites. Genome and
transcriptome analysis of S. neurona has previously revealed that BKIs may inhibit
SnCDPK1 in vitro and has been confirmed using four different BKIs at EC50 values of 40120 nM. In addition, host cell invasion can be blocked by the time-dependent treatment
using BKIs. BKI-1553 seems to be a promising candidate against S. neurona causing EPM
[78].
Ethanol is a short-chain alcohol that enhances calcium concentration in various vertebrate
cells by impacting signal transduction [87]. Calcium ionophore A23187 is a highly
selective ionophore. It can form highly stable complex with calcium that passes through
the cell membrane when required. This leads to increase in intracellular calcium levels
[88].
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Objectives for the research associated with this project include a) confirming that S.
neurona motility is actin-based and b) determining whether microneme secretion by S.
neurona is calcium-dependent.

2.2

Materials and Methods

2.2.1 Chemicals
Cytochalasin-D (Sigma-Aldrich, Saint Louis, MO) was dissolved in DMSO at 1 mM and
stored at -200C, BAPTA-AM (BioVision Inc., Milpitas, CA) was dissolved in DMSO at
30 mM and stored at -200C, BKI-1553 [79] was dissolved in DMSO at 100 µM and stored
at -200C, Calcium ionophore A23187 (Sigma-Aldrich, Saint Louis, MO) was dissolved in
DMSO at 20 µM and stored at -200C.
2.2.2

Antibodies

Rabbit α-SnMIC10 [37], Rabbit α-SnSPR1 [74], Rabbit α-SnSAG4 [86].
2.2.3

Parasite preparation

Merozoites of S. neurona were maintained by serial passage in bovine turbinate cells as
described previously [37]. Briefly, parasites were harvested by passage through 3.0 –
micron filters and washed in HBSS (Hank’s balanced salt solution) containing 0.1 mM
EGTA and 10 mM HEPES (referred as HHE).
2.2.4

Motility Assay

Freshly egressed S. neurona merozoites were harvested as described above and
resuspended in fresh DMEM (Dulbecco’s modified eagle medium) containing 10% goat
serum. Parasites were counted using a hemocytometer and each approximately 2 x 105
parasites were added to each reaction tube.
Cytochalasin-D (CD, actin polymerization inhibitor) associated experiments: 0.1% DMSO
(diluted in DMEM) was used as the control for each of the experiments. CD stock was
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diluted to different concentrations (1 µM, 2 µM) in DMEM and incubated in centrifuge
tubes with resuspended batch of parasites for 30 minutes.
BAPTA-AM (calcium chelator) associated experiments: 0.3% DMSO (diluted in DMEM)
was used as the control for each of the experiments. BAPTA stock was diluted to different
concentrations (10 mM, 20 mM, and 30 mM) in DMEM and incubated in centrifuge tubes
with resuspended batch of parasites for 10 minutes.
A few drops of incubated parasites (~ 30µl) were added to a glass slide for each experiment
and incubated at 370C for 2 minutes. Live videos of parasites were then captured. Each
treatment was performed in triplicate for one batch of freshly egressed parasites. Same
experiment was performed with different batches of parasites to confirm reproducibility of
results.
2.2.5

Video microscopy

A random field was selected on each slide. 20 second live video without intervals was
captured at X 10 objective lens under an inverted fluorescence microscope (Nikon
ECLIPSE Ti). Randomness for field selection was ensured by capturing the video right
after incubation on the area of slide that automatically falls under the microscope lens. DSQiMc-U3 camera was used and videos were analyzed using Nikon NIS-Elements software.
Number of parasites moving and total number of parasites in the field were counted using
Nikon software. All the data was graphically represented using GraphPad Prism version
9.3.1.
2.2.6

Microneme Secretion Assay

The excretory/secretory antigen fraction from S. neurona was assayed as previously
described for T. gondii [43]. Freshly egressed S. neurona merozoites were harvested as
described above. Parasites were counted using a hemocytometer and appropriate number
of parasites were divided between the standards (~3x105 per 10 µl for 50%) and secretion
samples (~6x105 per 10 µl). Merozoites used for secretion samples were washed once with
secretion medium (RPMI medium with 20 µM HEPES and 3% Fetal bovine serum).
Whereas, the merozoites harvested for standards were washed with PBS. Parasites were
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resuspended in secretion medium to achieve desired concentration (~6x105 per 10 µl) and
added to each microfuge tube for incubation with assigned drug treatment.
Drug treatments were performed the following way:
Inducers such as ethanol (1%) and ionophore A23187 (0.2 µM) were added to centrifuge
tubes containing secretion medium 20 minutes before adding the parasites and incubated
at 250C for 2 minutes. 0.1% DMSO was used as the control for ionophore treated parasites.
Inhibitor such as BKI-1553 was added at 1 µM concentration to centrifuge tube containing
secretion medium just before adding the parasites and incubated at 370C for 65 minutes.
This is done in order to avoid pre-leaching of calcium from parasites before incubation.
0.1% DMSO was used as the control for BKI-1553 treated parasites.
Each tube was placed on ice for at least 2 minutes after incubation to stop protein secretion.
Merozoites were then removed from the secretion medium by centrifugation (two times at
1,000 g, 5 min, 40C), and supernatants were either stored at -200C or immediately processed
for Western blot analysis, as described below. Each secretion sample tube had
approximately 6 x 105 per 10 µl parasite corresponding volume to estimate for proper
calculations of standards used.
2.2.7

Western Blotting

Supernatant proteins and whole parasite lysates were suspended in SDS sample buffer,
with or without 2-mercaptoethanol, and supplemented with protease inhibitor cocktail
composed of 4-(2-aminoethyl) benzenesulfonyl fluoride, E-64, bestatin, leupeptin,
aprotinin, and sodium EDTA (Sigma). Proteins were separated in 12% polyacrylamide
gels. For Western blot analysis, proteins were transferred to nitrocellulose membranes by
semi-dry electrophoretic transfer in Tris-glycine buffer (pH 8.3). Membranes were blocked
with PBS containing non-fat dry milk, 0.1% TWEEN 20, and 5% goat serum (GS), and
then incubated for 1.5 hours in primary antibody solution. After multiple washes with PBS
containing 0.1% GS and nonfat dry milk, the membranes were incubated with goat antirabbit IgG (1:10,000) secondary antibody conjugated to horseradish peroxidase (Jackson
ImmunoResearch Labs, Inc.) for an hour. After further washing, the membranes were
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processed for chemiluminescent detection using SuperSignal w substrate (Pierce) and
exposed to radiograph film or documented with an imaging system (BioRad ChemiDoc).
2.2.8

Quantification

To assess protein quantities, ImageJ analysis software was used. Briefly, each western blot
image was opened as 8-bit type and inverted into black (represents background) and white
(represents gel band). Each band was then selected by forming a rectangle around it. Each
rectangle was of equal size. Integrated density of each band was then measured using the
analysis tab. This represents the pixel density of each band which was used for further
calculations.
2.2.9

Standard Curves

Standard curves were generated using GraphPad Prism version 9.3.1. The percentage of
total protein content in parasites loaded on each gel was used. Percentages used on standard
curve included 25 %, 12.5 %, 6.25 % and 3.13 % of total protein content for each
experiment.
2.2.10 Calculations
Microneme-secreted protein content was calculated relative to the standards (total cellular
protein content) using ‘Predict’ function in GraphPad Prism version 9.3.1. This function
extrapolates the percentage of protein secreted for each sample based on the standard curve
created previously.
2.2.11 Statistical Analyses
Each experiment was performed in triplicate and the data was recorded as technical
replicates. Same experiment was performed with different batches (~ 2-3) of freshly
harvested parasites and the data was recorded as experimental replicates. Data from
motility assays were analyzed by Welch two-tailed t-test with pairwise yielding a
multiplicity adjusted P-value for each comparison. P-values less than 0.05 except stated
otherwise were considered to be statistically significant.
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2.3

Results

Gliding assays – Freshly harvested S. neurona merozoites were observed live for 20
seconds under a microscope for gliding motility as described in methods section above. As
shown in figure 2.3-1, parasites treated with 0.1% DMSO were captured for their motion
on the slide and depicted at various time points. Parasites showed three types of gliding as
seen in T. gondii, mainly helical motion, twirling and circular motion.
Upon treatment with Cytochalasin-D, the gliding of parasites was reduced significantly at
0.2 µM concentration as shown in figure 2.3-2. 0.1 µM of CD did not affect gliding of
parasites. Movement of parasites did not seem to be affected upon treatment with CD at
both 0.1 µM and 0.2 µM. Overall motility of parasite was reduced from 53% in non-treated
parasites to 46% in 0.1 µM CD-treated to 12% in 0.2 µM CD-treated parasites.
Upon treatment with different concentrations of BAPTA-AM (30 µM, 60 µM and 90 µM),
the results were inconsistent with each run as shown in figure 2.3-3 and thus inconclusive.
Microneme secretion assays – western blots were processed as shown in figures 2.3-4 (A),
2.3-5 (A), 2.3-6 and 2.3-7 (A) for treatment with or without 1% ethanol, 0.2 µM A23187,
100 µM BAPTA-AM and 1 µM BKI-1553 respectively. No amount of SAG4 was detected
when probed with SnSAG4 when treated with 1% ethanol or 0.2 µM A23187; suggesting
that there was no parasite lysis.
Upon treatment with 1% ethanol, the microneme-induced secretion increased but not
significantly as shown in figure 2.3-4 (B). Amount of SnMIC10 observed during secretion
enhanced from 11.7% (non-treated parasites) to 24.64% (ethanol-treated parasites) of total
protein content. Amount of SnSPR1 increased from 0 of total protein content in non-treated
parasites to 6.27% of total protein content in ethanol-treated parasites, indicating increased
parasite lysis.
Upon treatment with 0.2 µM A23187, the microneme-induced secretion increased but not
significantly as shown in figure 2.3-5 (B). Amount of SnMIC10 observed during secretion
enhanced from 13.9% (non-treated parasites) to 17.59% (A23187-treated parasites) of total
protein content. Amount of SnSPR1 increased from 1.49% in non-treated parasites to
5.86% of total protein content in drug-treated parasites, indicating increased parasite lysis.
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Upon treatment with 100 µM BAPTA-AM, the microneme-induced secretion was similar
to the amount of SnSPR1 observed during parasite lysis as shown in figure 2.3-6. Thus,
the quantitative comparison between each treatment was not made and the results were
inferred as inconclusive.
Upon treatment with 1 µM BKI-1553, the microneme-inhibited secretion decreased but not
significantly as shown in figure 2.3-7 (B). Amount of SnMIC10 observed during secretion
reduced from 24.21% (non-treated parasites) to 16.65% (BKI-1553-treated parasites) of
total protein content. Amount of SnSPR1 increased from 6.8% in non-treated parasites to
7.62% of total protein content in BKI-1553-treated parasites, indicating increased parasite
lysis. Also, amount of SnSAG4 detected in supernatant decreased from 3.27% in nontreated parasites to 2.66% of total protein content in drug-treated parasites; suggesting
reduction in parasite lysis.
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Figure 2.3-1 Freshly lysed parasites were treated with 0.1% DMSO and incubated at 370C
for 2 minutes before capturing a live video under a microscope with 10X objective.
A 20 second long video was captured and has been shown here at various time points (0
second, 4 seconds, 8 seconds, 12 seconds, 16 seconds and 20 seconds). White circle
represents a random field of observation for counting of the number of motile parasites for
each time point and is constant for every successive time point. To better understand the
gliding of S. neurona, one should monitor the change in path of each parasite under the
field of vision over time (from 0 second to 20 seconds).
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Figure 2.3-2 Difference in average percentage of motile parasites upon treatment with
0.1 µM CD (SEM ± 3.398) or 0.2 µM CD (SEM ± 1.75) or untreated (SEM ± 3.428). The
reduction in motility was significant (shown as asterisk) between untreated and 0.2 µM CD
(p = 0.0039) whereas no significant difference was found between untreated and 0.1 µM
CD (p = 0.289). Each treatment (6 x 105 parasite per 10 µl) was performed in triplicate and
averages have been reported. Error bars represent standard error of mean (SEM).
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Figure 2.3-3 Difference in average percentage of motile parasites upon treatment with
30 µM BAPTA-AM or 60 µM BAPTA-AM or 90 µM BAPTA-AM or untreated (0.1%
DMSO, 0.2% DMSO, 0.3% DMSO). Each treatment was performed in duplicate and
averages have been reported.
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Figure 2.3-4 (A) Western blot image showing differences in secretory fractions of
SnMIC10 (size of 24kDa) between untreated and parasites treated with 1% ethanol.
SnSPR1 (size of 17kDa) and SnSAG4 (size of 32kDa) are indicators of inadvertent cell
lysis. Standards were prepared as 25%, 12.5%, 6.25% and 3.13% of the cell lysate. (B)
Quantification of western blot bands showing induction in SnMIC10 secretion upon
treatment with 1% ethanol (untreated SEM ± 11.81; treated SEM ± 12.34) with no
significance (p = 0.529). SnSPR1 depicted increased cell lysis (untreated SEM ± 4.62;
treated SEM ± 2.485) but not significant (p = 0.17). SnSAG4 showed no cell lysis for either
treatment. Error bars represent standard error of mean (SEM).
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Figure 2.3-5 (A) Western blot image showing differences in secretory fractions of
SnMIC10 (size of 24kDa) between untreated and parasites treated with 0.2 µM A23187.
SnSPR1 (size of 17kDa) and SnSAG4 (size of 32kDa) are indicators of inadvertent cell
lysis. Standards were prepared as 25%, 12.5%, 6.25% and 3.13% of the cell lysate. (B)
Quantification of western blot bands showing induction in SnMIC10 secretion upon
treatment with 0.2 µM A23187 (untreated SEM ± 1.259; treated SEM ± 6.57) with no
significance (p = 0.675). SnSPR1 represented increased cell lysis (untreated SEM ± 1.42;
treated SEM ± 3.91) but not significant (p = 0.33). SnSAG4 showed no cell lysis for either
treatment. Error bars represent standard error of mean (SEM).
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Figure 2.3-6 Western blot image showing differences in secretory fractions of
SnMIC10 (size of 24kDa) between untreated and parasites treated with 100 µM BAPTAAM. SnSPR1 (size of 17kDa) is an indicator of inadvertent cell lysis. Standards were
prepared as 25%, 12.5%, 6.25% and 3.13% of the cell lysate.
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Figure 2.3-7 (A) Western blot image showing differences in secretory fractions of
SnMIC10 (size of 24kDa) between untreated and parasites treated with 1 µM BKI-1553.
SnSPR1 (size of 17kDa) and SnSAG4 (size of 32kDa) are indicators of inadvertent cell
lysis. Standards were prepared as 25%, 12.5%, 6.25% and 3.13% of the cell lysate. (B)
Quantification of western blot bands showing reduction in SnMIC10 secretion upon
treatment with 1 µM BKI-1553 (untreated SEM ± 1.235; treated SEM ± 2.202) without
significance (p = 0.127). SnSPR1 depicted increased cell lysis (untreated SEM ± 0.579;
treated SEM ± 0.892) but not significant. SnSAG4 represented reduction in cell lysis
(untreated SEM ± 1.566; treated SEM ± 1.089) but not significant (p = 0.42). Error bars
represent standard error of mean (SEM).
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2.4

Discussion

With more than 5000 species encompassing the phylum Apicomplexa, such pathogens
share complex life cycles with various developmental stages. Parasite motility and host cell
invasion has been long considered a vital contributing factor in the pathogenesis of the
associated disease. Virulence factors such as secreted proteins play a crucial role in
dissemination of infection caused by eukaryotic parasites. Understanding the parasite
gliding machinery at molecular level is of great importance for all Apicomplexa and still
has not been fully explored in some of these pathogens.
The underlying questions to motility of another coccidian parasite, S. neurona, and its
initial interaction with the host cell have yet to be answered. CD inhibits all three modes
of extracellular motility in T. gondii at a concentration of 1 µM. Significant reduction in
motility has been observed since parasite motility changes from 10% in non-treated
parasites to 0% in CD-treated parasites [64]. Results obtained from this study have been in
complete agreement with the conclusions made for T. gondii [76, 81, 82]. Firstly, we
conclude that gliding motility of S. neurona depends heavily on actin filament
polymerization in the parasite. As anticipated, there is at least three-fold reduction in the
gliding of S. neurona merozoites upon treatment with CD at 0.2 µM concentration. This
leads us to infer that inhibiting actin polymerization at higher concentrations may even
paralyze the parasite completely. This actin-based gliding may be acting as a driving force
for host cell invasion, which still needs to be confirmed.
Second, we have observed that S. neurona microneme secretion is probably calciumdependent. Suppression of TgCDPK1, a member of CDPK family, leads to failure in
upregulation of microneme secretion and thus disrupts host cell invasion and egress of
parasites [85, 86]. Targeting CDPK1 in S. neurona via BKI has been shown to inhibit
parasite growth both in vitro and in vivo [78]. This suggests that parasite motility and
invasion can be calcium-dependent.
Spot densitometry has been used for analysis of kinetics of SnMIC10, which reveals that
approximately 15–18% of the total cellular SnMIC10 is actively secreted by extracellular
S. neurona merozoites. Approximately 6% of the total SnSAG4 or 9% of total parasite
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actin is detected in the supernatants of secretion assay, demonstrating some inadvertent cell
lysis during the incubation [37].
Ethanol has been used to observe its effect on microneme discharge in T. gondii. Upon
treatment of purified T. gondii tachyzoites with 0.92% of ethanol for 2 minutes, ethanol
seems to induce secretion of micronemal proteins MIC2 and MIC4. Ethanol-induced
microneme secretion is 40% more effective as compared to other alcohols. Thus, ethanol
elevates T. gondii calcium by mobilizing it from intracellular stores [42]. Whereas, the
calcium ionophore A23187 has been shown to induce secretion of micronemal proteins
MIC2 and MIC4 in T. gondii [89].
As expected, our results support the observations from previous studies in T. gondii. When
extracellular S. neurona is treated with 1% ethanol (calcium inducer), we observe a twofold induction in microneme secretion of the parasite while probing with SnMIC10
antibody. Whereas, we have obtained ~1.5 times (not significant) stimulation of
microneme secretion upon treatment with 0.2 µM calcium ionophore A23187 (another
calcium inducer).
In case of S. neurona CDPK1-based study, BKI-1553 has been reported to be an effective
candidate for BKI-based therapy for EPM [78]. After performing microneme secretion
assay on S. neurona merozoites, we have obtained approximately 1.5 fold (not significant)
inhibition when treated with the 1 µM BKI-1553. As mentioned previously, S. neurona
encodes for 8 CDPK genes that are orthologues of T. gondii CDPKs specifically TgCDPK3
[78, 86]. It is possible that since the activity of CDPKs is not completely understood in S.
neurona due to the complexity of cell signaling involved, there might be other CDPKs
compensating for the CDPK1 inhibition via the use of BKI-1553.
To decipher the role played by intracellular calcium in gliding of S. neurona, we have
performed motility assays with BAPTA-AM. When freshly harvested S. neurona
merozoites are treated with 30-90 µM BAPTA-AM, a cell-permeable intracellular calcium
chelator, the results are inconsistent with every assay. Even though treating T. gondii
parasites with 50 µM BAPTA-AM has been observed to be effective in inhibition of
motility and host cell invasion [90]; our results for S. neurona are inconclusive. S. neurona
merozoites are treated with 100 µM BAPTA-AM to investigate dependency of microneme
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secretion on calcium. However, the results are inconclusive since high amount of parasite
lysis is observed (almost comparable to the amount of microneme secreted by S. neurona).

2.5

Future Directions

Since we have demonstrated in our studies that actin-based and calcium-dependent
secretion-associated motility is required for S. neurona, some additional studies to address
the limitations of our research is warranted. Conventional western blot is a semiquantitative assay that includes multiple steps and is highly prone to variation when results
are reproduced. Due to this, every step needs to be optimized before reporting results on
samples. One of the most important steps is proper utilization of homogenization buffer
during sample preparation. Significant advances have been made to address such issues in
addition to lowering the processing time of a blot. Moreover, certain non-traditional
western blotting techniques such as microfluidic systems and capillary electrophoresis
have been discovered recently. It will be interesting to see how the data changes if these
techniques are used as an alternative to western blot to evaluate the secreted microneme
protein from cellular content.
Since the research has not taken toxicity associated with the motility-inhibition drugs into
consideration, it will be useful to perform some cytotoxicity/cell viability assays (such as
enzyme-based LDH or membrane integrity viability dyes) for a broader picture. A
molecular target indirectly related to actin monomers might also be a possibility for activity
of CD on S. neurona.
Exploring key effector molecules that orchestrate glideosome signaling to observe whether
the inhibition/induction of microneme secretion is directly related to S. neurona motility
needs to be elucidated. Investigation into propagation of BKI-treated parasites over time
may lead us to better understand about the existence of any CDPK1-independent motility.
Since motility-associated post-translational modifications have previously been reported
in T. gondii, it will be interesting to examine if any such modifications exist in S. neurona
that interact with glideosome assembly, regulation and function.
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